Abstract

    Open Access Opinion Article ID: GJIDCR-6-129

    Shock therapy to treat the Novel Coronavirus Disease (COVID-19) by ddNTPs

    Yeping Tan*

    The Novel Coronavirus (SARS-CoV-2) has caused a massive global outbreak, presenting a significant public health emergency and international concern. Thousands of critically ill patients are dying daily. To date, there are no clinically approved antiviral drug available to cure the Novel Coronavirus infections.  I highly recommend the clinical trial of 2’,3’-dideoxyribonucleoside triphosphate (ddNTPs, except ddTTP) to be used for the Novel Coronavirus Disease (COVID-19) antiviral therapy.

    Keywords:

    Published on: May 20, 2020 Pages: 13-13

    Full Text PDF Full Text HTML DOI: 10.17352/2455-5363.000029
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

    Indexing/Archiving

    Pinterest on GJIDCR